The company states: “Onconetix (ONCO) announced that new clinical data of Proclarix was presented on March 23, 2025 during the 2025 European Association of Urology congress, which data further ...
Onco-Innovations Ltd. ( ($TSE:ONCO) ) has shared an update. Onco-Innovations Limited announced that its second-generation nanoparticle formulation ...
As of 10:09:01 a.m. EDT. Market Open. CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), (formerly Blue Water Biotech, Inc. (BWV)), a cancer ...